Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background Nitrous oxide (N₂O) is commonly used during general anesthesia for ovum pickup during in vitro fertilization (IVF) cycles. N₂O deactivates methionine synthetase, thereby reducing the amount of thymidine available for DNA synthesis in dividing cells, which might be the reason for the low implantation rate or increased frequency of early pregnancy loss. The aim of this study is to find out the IVF outcomes after exposure to either isoflurane or a combination of isoflurane + N₂O during anesthesia administration in the oocyte retrieval procedure. Methods This retrospective analysis was conducted on 250 patients undergoing IVF procedures who received anesthesia with isoflurane + N₂O or only isoflurane. Medical records were obtained for patient data, anesthesia details, and IVF outcomes. The primary objective was to compare the pregnancy rates between the two groups. The secondary objectives included comparing fertilization rates, oocyte grades, and cleavage rates. Results The pregnancy rates and cleavage rates measured on Day 2 and Day 3 of fertilization were similar in both groups. The fertilization rate (median(IQR)) was higher in the Iso group, but the difference was not statistically significant (air - 100 (87.5-100) vs. N₂O - 100 (83.3-100); P = 0.07). The number of oocytes retrieved of Grade 1 and Grade 2 quality was similar in both groups, while Grade 3 oocytes retrieved were significantly higher in the N0 group. Conclusion While the use of N₂O during oocyte retrieval appears to be associated with an increased number of lower-quality oocytes, it does not negatively affect fertilization, cleavage, or pregnancy rates.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12399022PMC
http://dx.doi.org/10.7759/cureus.89146DOI Listing

Publication Analysis

Top Keywords

oocyte retrieval
12
pregnancy rates
12
nitrous oxide
8
vitro fertilization
8
ivf outcomes
8
isoflurane n₂o
8
cleavage rates
8
oocytes retrieved
8
fertilization
6
rates
6

Similar Publications

Study Question: Can patient age and ovarian reserve tests predict the number of cryopreserved oocytes in patients undergoing one or more ovarian stimulation cycles for elective oocyte cryopreservation (EOC)?

Summary Answer: A predictive model incorporating patient age, antral follicle count (AFC), anti-Müllerian hormone (AMH), and FSH levels achieved the greatest predictive accuracy.

What Is Known Already: As a consequence of societal evolution, women are increasingly delaying starting a family. However, the natural decline in ovarian reserve and oocyte quality as age advances can increase the risk of age-related fertility decline (ARFD) and involuntary childlessness.

View Article and Find Full Text PDF

Study Question: Do IVF laboratory workflows influence the mean blastulation rate per cohort of inseminated metaphase II oocytes (m-BR)?

Summary Answer: Neither the total number of procedures nor the workload per operator affected m-BR; instead, each additional hour in the interval from ovulation trigger to oocyte denudation (range 36-44 h) was associated with a measurable decline, especially beyond the 40-h threshold.

What Is Known Already: Control of laboratory conditions and standardized protocols are essential for optimizing m-BR in IVF. While advancements in technology and culture systems have improved ART outcomes, the effect of laboratory managerial decisions and procedural timing on embryological outcomes remains unclear.

View Article and Find Full Text PDF

The management of assisted reproductive technology (ART) in predicted hyper-responders to ovarian stimulation represents a complex and challenging clinical scenario, whereby the benefits of higher oocyte yield must be balanced against the drawbacks and risks of ovarian hyperstimulation syndrome. This review explores advances in ART for hyper-responders, focusing on adapted stimulation protocols, ovulation triggering, cryopreservation, and personalized strategies to optimize outcomes. In-vitro maturation of oocytes, an emerging alternative, is gaining traction for increasing live birth rates in selected cases and expert centers.

View Article and Find Full Text PDF

Recent advancements in genomic technology have increased interest in using calves as oocyte sources through the laparoscopic ovum pick-up (LOPU) method, which shortens generation intervals and enhances genetic gain. This study aimed to produce embryos in vitro using oocytes from endangered Anatolian Native Black calves and to increase the number of embryos in the gene bank through LOPU, a method not previously studied in Turkey. Four Anatolian Native Black calves, approximately 3 months old, were used.

View Article and Find Full Text PDF

Objective: The aim of this retrospective cohort study was to evaluate the relationship between leading follicle size at the time of human chorionic gonadotropin (hCG) trigger and live birth rates in Patient-Oriented Strategies Encompassing Individualised Oocyte Number (POSEIDON) groups 3 and 4 undergoing assisted reproductive technology cycles using a gonadotropin releasing hormone (GnRH) antagonist protocol. The objective was to identify the optimal leading follicle size for maximizing live birth outcomes in this challenging patient population.

Material And Methods: This retrospective cohort study included POSEIDON groups 3 and 4 poor responders aged 20-42 years undergoing intracytoplasmic sperm injection with GnRH antagonist protocol between January 2015 and July 2021.

View Article and Find Full Text PDF